Top

Quality of Life Research

Gepubliceerd in:

01-03-2014

Fatigue interference with daily living among patients with inflammatory bowel disease

Auteurs: Randi Opheim, May Solveig Fagermoen, Tomm Bernklev, Lars-Petter Jelsness-Jorgensen, Bjorn Moum

Gepubliceerd in: Quality of Life Research | Uitgave 2/2014

Abstract

Purpose

The purpose of the study was to examine fatigue interference with daily living in patients with inflammatory bowel disease (IBD) and to explore relationships between severe fatigue interference and socio-demographic and clinical variables, including use of complementary and alternative medicine (CAM).

Methods

Data were collected using self-report questionnaires from adult IBD outpatients. Fatigue interference was assessed with the 5-item Fatigue Severity Scale, and scores ≥5 were defined as severe fatigue interference. CAM use was assessed with the International CAM Questionnaire. Multivariate logistic regression analysis was used to examine associations between severe fatigue interference and socio-demographic factors, clinical factors, and CAM use.

Results

In total, 428 patients had evaluable questionnaires (response rate 93 %). Severe fatigue interference was reported by 39 % of the total sample. Patients with Crohn’s disease (CD) (n = 238) were more likely than patients with ulcerative colitis (UC) (n = 190) to report severe fatigue interference (43 and 33 %, respectively, p = 0.003). In addition, patients reporting severe fatigue interference were more likely to have active disease than patients without severe fatigue interference (p < 0.001 for both diagnoses). Patients with inactive disease had scores comparable to the general population. Factors independently associated with severe fatigue interference in UC included disease activity and CAM use, while in CD they included disease activity and current smoking.

Conclusions

Severe fatigue interference is common among IBD patients with active disease. Among patients with UC, but not CD, CAM use was associated with severe fatigue interference. The relationship between fatigue interference and personal factors should be considered further in subsequent studies.

vorige artikel Consequences of visual height intolerance for quality of life: a qualitative study

volgende artikel Assessment of health-related quality of life 6 years after childhood cochlear implantation

Cosnes, J., Gower-Rousseau, C., Seksik, P., & Cortot, A. (2011). Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 140(6), 1785–1794. doi:10.1053/j.gastro.2011.01.055.PubMedCrossRef

van Langenberg, D. R., & Gibson, P. R. (2010). Systematic review: Fatigue in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 32(2), 131–143. doi:10.1111/j.1365-2036.2010.04347.x.CrossRef

Graff, L. A., Vincent, N., Walker, J. R., Clara, I., Carr, R., Ediger, J., et al. (2011). A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflammatory Bowel Diseases, 17(9), 1882–1889. doi:10.1002/ibd.21580.PubMedCrossRef

Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. A. (2011). Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflammatory Bowel Diseases, 17(7), 1564–1572. doi:10.1002/ibd.21530.PubMedCrossRef

Hauser, W., Stallmach, A., Kocalevent, R. D., Rose, M., & Fliege, H. (2005). Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis—An explorative study. GMS Psycho-Social Medicine, 2, 1–10.

Minderhoud, I. M., Oldenburg, B., van Dam, P. S., & van Berge Henegouwen, G. P. (2003). High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. American Journal of Gastroenterology, 98(5), 1088–1093. doi:10.1111/j.1572-0241.2003.07414.x.PubMedCrossRef

Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. (2012). Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease. World Journal of Gastroenterology, 18(5), 445–452. doi:10.3748/wjg.v18.i5.445.PubMedCentralPubMedCrossRef

Romberg-Camps, M. J., Bol, Y., Dagnelie, P. C., Hesselink‐van de Kruijs, M. A. M., Kester, A. D., Engels, L. G., et al. (2010). Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflammatory Bowel Diseases, 16(12), 2137–2147. doi:10.1002/ibd.21285.PubMedCrossRef

Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. A. (2011). Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 33(1), 106–114. doi:10.1111/j.1365-2036.2010.04498.x.CrossRef

10.

Kalaitzakis, E., Carlsson, E., Josefsson, A., & Bosaeus, I. (2008). Quality of life in short-bowel syndrome: Impact of fatigue and gastrointestinal symptoms. Scandinavian Journal of Gastroenterology, 43(9), 1057–1065. doi:10.1080/00365520802078325.PubMedCrossRef

11.

Banovic, I., Gilibert, D., & Cosnes, J. (2010). Crohn’s disease and fatigue: Constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life. Psychology, Health & Medicine, 15(4), 394–405. doi:10.1080/13548501003759155.CrossRef

12.

Bol, Y., Duits, A. A., Vertommen-Mertens, C. E., Hupperts, R. M., Romberg-Camps, M. J., Verhey, F. R., et al. (2010). The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: A comparison with ulcerative colitis. Journal of Psychosomatic Research, 69(1), 43–49. doi:10.1016/j.jpsychores.2009.11.011.PubMedCrossRef

13.

Krupp, L. B., Alvarez, L. A., LaRocca, N. G., & Scheinberg, L. C. (1988). Fatigue in multiple sclerosis. Archives of Neurology, 45(4), 435–437.PubMedCrossRef

14.

Shen, J., Barbera, J., & Shapiro, C. M. (2006). Distinguishing sleepiness and fatigue: Focus on definition and measurement. Sleep Medicine Reviews, 10(1), 63–76. doi:10.1016/j.smrv.2005.05.004.PubMedCrossRef

15.

Swain, M. G. (2000). Fatigue in chronic disease. Clinical Science, 99(1), 1–8.PubMedCrossRef

16.

Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.PubMedCrossRef

17.

Whitehead, L. (2009). The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management, 37(1), 107–128. doi:10.1016/j.jpainsymman.2007.08.019.PubMedCrossRef

18.

Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: A practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56(2), 157–170. doi:10.1016/S0022-3999(03)00371-4.PubMedCrossRef

19.

Casati, J., Toner, B. B., de Rooy, E. C., Drossman, D. A., & Maunder, R. G. (2000). Concerns of patients with inflammatory bowel disease: A review of emerging themes. Digestive Diseases and Sciences, 45(1), 26–31.PubMedCrossRef

20.

Drossman, D. A., Patrick, D. L., Mitchell, C. M., Zagami, E. A., & Appelbaum, M. I. (1989). Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Digestive Diseases and Sciences, 34(9), 1379–1386.PubMedCrossRef

21.

Czuber-Dochan, W., Dibley, L. B., Terry, H., Ream, E., & Norton, C. (2012). The experience of fatigue in people with inflammatory bowel disease: An exploratory study. Journal of Advanced Nursing,. doi:10.1111/jan.12060.PubMed

22.

Stjernman, H., Tysk, C., Almer, S., Strom, M., & Hjortswang, H. (2010). Worries and concerns in a large unselected cohort of patients with Crohn’s disease. Scandinavian Journal of Gastroenterology, 45(6), 696–706. doi:10.3109/00365521003734141.PubMedCrossRef

23.

Wolfe, B. J., & Sirois, F. M. (2008). Beyond standard quality of life measures: The subjective experiences of living with inflammatory bowel disease. Quality of Life Research, 17(6), 877–886. doi:10.1007/s11136-008-9362-1.PubMedCrossRef

24.

Czuber-Dochan, W., Ream, E., & Norton, C. (2013). Review article: Description and management of fatigue in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 37(5), 505–516. doi:10.1111/apt.12205.CrossRef

25.

Olsen, S. A. (2009). A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occupational Therapy International, 16(1), 57–70. doi:10.1002/oti.266.PubMedCrossRef

26.

Skovgaard, L., Nicolajsen, P. H., Pedersen, E., Kant, M., Fredrikson, S., Verhoef, M., et al. (2012). Use of complementary and alternative medicine among people with multiple sclerosis in the Nordic countries. Autoimmune Diseases,. doi:10.1155/2012/841085.PubMedCentralPubMed

27.

Taibi, D. M., & Bourguignon, C. (2003). The role of complementary and alternative therapies in managing rheumatoid arthritis. Family and Community Health, 26(1), 41–52.PubMedCrossRef

28.

Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., & Zwahlen, M. (2012). How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integrative Cancer Therapies, 11(3), 187–203. doi:10.1177/1534735411423920.PubMedCrossRef

29.

Hilsden, R. J., Verhoef, M. J., Rasmussen, H., Porcino, A., & Debruyn, J. C. (2011). Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 17(2), 655–662. doi:10.1002/ibd.21360.PubMedCrossRef

30.

Opheim, R., Bernklev, T., Fagermoen, M. S., Cvancarova, M., & Moum, B. (2012). Use of complementary and alternative medicine in patients with inflammatory bowel disease: Results of a cross-sectional study in Norway. Scandinavian Journal of Gastroenterology, 47(12), 1436–1447. doi:10.3109/00365521.2012.725092.PubMedCrossRef

31.

Siegel, K., Brown-Bradley, C. J., & Lekas, H. M. (2004). Strategies for coping with fatigue among HIV-positive individuals fifty years and older. AIDS Patient Care and STDS, 18(5), 275–288. doi:10.1089/108729104323076016.PubMedCrossRef

32.

Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., et al. (2005). Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian Journal of Gastroenterology, 19(Suppl A), 5–36.

33.

Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn’s-disease activity. Lancet, 1(8167), 514.PubMedCrossRef

34.

Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.PubMedCentralPubMedCrossRef

35.

Higgins, P. D., Schwartz, M., Mapili, J., Krokos, I., Leung, J., & Zimmermann, E. M. (2005). Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut, 54(6), 782–788. doi:10.1136/gut.2004.056358.PubMedCentralPubMedCrossRef

36.

D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., et al. (2007). A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology, 132(2), 763–786. doi:10.1053/j.gastro.2006.12.038.PubMedCrossRef

37.

Vermeire, S., Schreiber, S., Sandborn, W. J., Dubois, C., & Rutgeerts, P. (2010). Correlation between the Crohn’s disease activity and Harvey-Bradshaw indices in assessing Crohn’s disease severity. Clinical Gastroenterology and Hepatology, 8(4), 357–363. doi:10.1016/j.cgh.2010.01.001.PubMedCrossRef

38.

Lerdal, A., Wahl, A., Rustoen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health, 33(2), 123–130. doi:10.1080/14034940410028406.PubMedCrossRef

39.

Lerdal, A., & Kottorp, A. (2011). Psychometric properties of the Fatigue Severity Scale-Rasch analyses of individual responses in a Norwegian stroke cohort. International Journal of Nursing Studies, 48(10), 1258–1265. doi:10.1016/j.ijnurstu.2011.02.019.PubMedCrossRef

40.

Mills, R., Young, C., Nicholas, R., Pallant, J., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Multiple Sclerosis, 15(1), 81–87. doi:10.1177/1352458508096215.PubMedCrossRef

41.

Quandt, S. A., Verhoef, M. J., Arcury, T. A., Lewith, G. T., Steinsbekk, A., Kristoffersen, A. E., et al. (2009). Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). Journal of Alternative and Complementary Medicine, 15(4), 331–339. doi:10.1089/acm.2008.0521.PubMedCentralCrossRef

42.

NCCAM (2012). What is CAM? http://nccam.nih.gov/health/whatiscam/. Accessed 10 May 2013.

43.

Mancuso, C. A., Rincon, M., Sayles, W., & Paget, S. A. (2006). Psychosocial variables and fatigue: A longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. Journal of Rheumatology, 33(8), 1496–1502.PubMed

44.

Kleinman, L., Zodet, M. W., Hakim, Z., Aledort, J., Barker, C., Chan, K., et al. (2000). Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Quality of Life Research, 9(5), 499–508.PubMedCrossRef

45.

Lerdal, A., Celius, E. G., & Moum, T. (2003). Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Multiple Sclerosis, 9(5), 509–514.PubMedCrossRef

46.

Omdal, R., Mellgren, S. I., Koldingsnes, W., Jacobsen, E. A., & Husby, G. (2002). Fatigue in patients with systemic lupus erythematosus: Lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. Journal of Rheumatology, 29(3), 482–486.PubMed

47.

Hoivik, M. L., Bernklev, T., Solberg, I. C., Cvancarova, M., Lygren, I., Jahnsen, J., et al. (2012). Patients with Crohn’s disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study. Journal of Crohn’s Colitis, 6(4), 441–453. doi:10.1016/j.crohns.2011.10.001.PubMedCrossRef

48.

Graff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., et al. (2006). The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clinical Gastroenterology and Hepatology, 4(12), 1491–1501. doi:10.1016/j.cgh.2006.09.027.PubMedCrossRef

49.

Lix, L. M., Graff, L. A., Walker, J. R., Clara, I., Rawsthorne, P., Rogala, L., et al. (2008). Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflammatory Bowel Diseases, 14(11), 1575–1584. doi:10.1002/ibd.20511.PubMedCrossRef

50.

Casellas, F., Arenas, J. I., Baudet, J. S., Fabregas, S., Garcia, N., Gelabert, J., et al. (2005). Impairment of health-related quality of life in patients with inflammatory bowel disease: A Spanish multicenter study. Inflammatory Bowel Diseases, 11(5), 488–496.PubMedCrossRef

51.

Gibson, P. R., Weston, A. R., Shann, A., Florin, T. H., Lawrance, I. C., Macrae, F. A., et al. (2007). Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn’s disease. Journal of Gastroenterology and Hepatology, 22(8), 1306–1312. doi:10.1111/j.1440-1746.2007.04930.x.PubMedCrossRef

52.

Singh, S., Blanchard, A., Walker, J. R., Graff, L. A., Miller, N., & Bernstein, C. N. (2011). Common symptoms and stressors among individuals with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology, 9(9), 769–775. doi:10.1016/j.cgh.2011.05.016.PubMedCrossRef

53.

Jelsness-Jorgensen, L. P., Bernklev, T., & Moum, B. (2012). Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report. Journal of Psychosomatic Research, 73(6), 469–472. doi:10.1016/j.jpsychores.2012.08.009.PubMedCrossRef

54.

Talley, N. J., Abreu, M. T., Achkar, J. P., Bernstein, C. N., Dubinsky, M. C., Hanauer, S. B., et al. (2011). An evidence-based systematic review on medical therapies for inflammatory bowel disease. American Journal of Gastroenterology, 106(Suppl 1), S2–25. doi:10.1038/ajg.2011.58. quiz S26.PubMedCrossRef

55.

Loftus, E. V., Feagan, B. G., Colombel, J. F., Rubin, D. T., Wu, E. Q., Yu, A. P., et al. (2008). Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn’s disease: Patient-reported outcomes of the CHARM trial. American Journal of Gastroenterology, 103(12), 3132–3141. doi:10.1111/j.1572-0241.2008.02175.x.PubMedCrossRef

56.

Minderhoud, I. M., Samsom, M., & Oldenburg, B. (2007). Crohn’s disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue? World Journal of Gastroenterology, 13(14), 2089–2093.PubMed

57.

Loge, J. H., Ekeberg, O., & Kaasa, S. (1998). Fatigue in the general Norwegian population: Normative data and associations. Journal of Psychosomatic Research, 45(1), 53–65.PubMedCrossRef

58.

Bultmann, U., Kant, I., Kasl, S. V., Beurskens, A. J., & van den Brandt, P. A. (2002). Fatigue and psychological distress in the working population: Psychometrics, prevalence, and correlates. Journal of Psychosomatic Research, 52(6), 445–452.PubMedCrossRef

59.

Ng, S. C., Bernstein, C. N., Vatn, M. H., Lakatos, P. L., Loftus, E. V, Jr, Tysk, C., et al. (2013). Geographical variability and environmental risk factors in inflammatory bowel disease. Gut, 62(4), 630–649. doi:10.1136/gutjnl-2012-303661.PubMedCrossRef

60.

Sirois, F. M. (2009). Editorial: Psychological adjustment to inflammatory bowel disease: The importance of considering disease activity. American Journal of Gastroenterology, 104(12), 2970–2972. doi:10.1038/ajg.2009.537.PubMedCrossRef

61.

Ranjbaran, Z., Keefer, L., Stepanski, E., Farhadi, A., & Keshavarzian, A. (2007). The relevance of sleep abnormalities to chronic inflammatory conditions. Inflammation Research, 56(2), 51–57. doi:10.1007/s00011-006-6067-1.PubMedCrossRef

62.

Young, K. E., & White, C. A. (2006). The prevalence and moderators of fatigue in people who have been successfully treated for cancer. Journal of Psychosomatic Research, 60(1), 29–38. doi:10.1016/j.jpsychores.2005.03.011.PubMedCrossRef

Titel: Fatigue interference with daily living among patients with inflammatory bowel disease
Auteurs: Randi Opheim
May Solveig Fagermoen
Tomm Bernklev
Lars-Petter Jelsness-Jorgensen
Bjorn Moum
Publicatiedatum: 01-03-2014
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 2/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-013-0508-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2014

Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL

Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases

How good is “very good”? Translation effect in the racial/ethnic variation in self-rated health status

The valuation of the EQ-5D in Portugal

The relationship between negative life events, psychological distress and life satisfaction: a population-based study

Comparative validation of the WOMAC osteoarthritis and Lequesne algofunctional indices in Greek patients with hip or knee osteoarthritis